Asterias' OPC1 cells show durable effect after a year in spinal cord injury patients

Stock Information for Asterias Biotherapeutics Inc. Common Series A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Asterias Biotherapeutics Inc. Common Series A

AMENDED: Astron Connect Inc. Announces the Annual General Meeting was held on December 30, 2024
Astron Connect Inc. Announces the Annual General Meeting was held on December 20, 2024
Astron Connect Inc. Announces the Annual General Meeting will be held in the boardroom at 2900 - 733 Seymour Street, Vancouver, British Columbia at 10:00 a.m. on Monday, December 30, 2024
Astron Connect Inc. Announces Closing of $400,000 Non-Brokered Private Placement
Astron Connect Inc. Announces $400,000 Non-Brokered Private Placement
Astron Connect Inc. Reports First Quater 2024 Results
Astron Connect Inc. Reports Full Year 2023 Results
Astron Connect Inc. Announces Change of Auditor

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.